Underwriters Exercise Option on BG Medicine IPO

Following the exercise of the over-allotment option, BG's net proceeds from the IPO were roughly $35 million.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories